Encell

Provider of services for stem cell research for drug development

placeSeoul, Seoul, South Korea calendar_todayFounded 2018 groups104 employees language encellinc.com

Registered entities

Investor mix

11 investors on record; lead investors include Won & Partners, Ntels, Samsung Venture Investment, Smile Gate Investment.

Investor typeCountShare
Venture capital655%
Private equity327%
Accelerator & incubator19%
Other / undisclosed19%
Coming soon